日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Estimation of Prevention-Effective CAB-LA Concentrations Among Men Who Have Sex With Men (MSM) and Transgender Women (TGW) in HPTN 083

HPTN 083 中男男性行为者 (MSM) 和跨性别女性 (TGW) 预防有效 CAB-LA 浓度的估计

期刊:Journal of Infectious Diseases
影响因子:
doi:10.1093/infdis/jiaf561
Hanscom, Brett; Marzinke, Mark A; Li, Xinnong; Donnell, Deborah; Bies, Robert; Hendrix, Craig W; Wang, Zhe; Acuipil, Carolina; Rinehart, Alex; Collins, Jon W; Rooney, James F; Soto Torres, Lydia; Richardson, Paul; Chariyalerstsak, Suwat; Valdez Ramalho Madruga, Jose; Hurt, Christopher B; Magnus, Manya; Frank, Ian; McCauley, Marybeth; Grinsztejn, Beatriz; Landovitz, Raphael J
PTN
多发性硬化症
发表日期：2026
文献求助 收藏

Clinical Pharmacokinetics and Safety of Orally Administered VH4011499, a New HIV-1 Capsid Inhibitor, in Adults Without HIV

在未感染 HIV 的成年人中，口服新型 HIV-1 衣壳抑制剂 VH4011499 的临床药代动力学和安全性研究

期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-025-01129-y
Thakkar, Nilay; Griesel, Rulan; Pierce, Amy; Bainbridge, Veronica; Shepherd, Bronagh; Angelis, Konstantinos; Tomlinson, Andrew; Gandhi, Yash; Brimhall, Darin; Spears, Brian; Anderson, Daijha; Pinnick, Emma; Acuipil, Carolina; McCoig, Cynthia; Baker, Mark; Benn, Paul
HIV
炎症/感染
微生物学
发表日期：2025
文献求助 收藏

Clinical Pharmacokinetics and Safety of a New HIV-1 Capsid Inhibitor, VH4004280, After Oral Administration in Adults Without HIV

新型 HIV-1 衣壳抑制剂 VH4004280 在非 HIV 感染成人口服给药后的临床药代动力学和安全性研究

期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-025-01154-x
Thakkar, Nilay; Griesel, Rulan; Pierce, Amy; Bainbridge, Veronica; Shepherd, Bronagh; Angelis, Konstantinos; Tomlinson, Andrew; Gandhi, Yash; Brimhall, Darin; Anderson, Daijha; Andrews, Susan; Acuipil, Carolina; McCoig, Cynthia; Baker, Mark; Benn, Paul
HIV
炎症/感染
微生物学
发表日期：2025
文献求助 收藏

Thigh Injections of Cabotegravir + Rilpivirine in Virally Suppressed Adults With HIV-1: A Substudy of the Phase 3b ATLAS-2M Study

在病毒载量受到抑制的 HIV-1 感染成人患者中，大腿注射卡博特韦+利匹韦林：ATLAS-2M 3b 期研究的子研究

期刊:Clinical Infectious Diseases
影响因子:
doi:10.1093/cid/ciae620
Ford, Susan L; Felizarta, Franco; Han, Kelong; Wang, Kehui; Crauwels, Herta; Dari, Anna; Masia, Mar; Garcia Deltoro, Miguel; Degen, Olaf; Angel, Jonathan B; Hsiao, Chiu-Bin; Acuipil, Carolina; Kolobova, Irina; Harrington, Conn; Rimler, Kelly; Spreen, William; D'Amico, Ronald
HIV
炎症/感染
微生物学
发表日期：2025
文献求助 收藏

Subcutaneous injections of cabotegravir plus rilpivirine long-acting in virally suppressed adults with HIV-1

对病毒载量受到抑制的 HIV-1 感染成人进行卡博特韦联合利匹韦林长效制剂的皮下注射

期刊:AIDS
影响因子:
doi:10.1097/QAD.0000000000004310
D'Amico, Ronald; Han, Kelong; Min, Sherene; DeMoor, Rebecca; St Clair, Marty; Ford, Susan L; Harrington, Conn; Bernal-Morell, Enrique; Lombaard, Johannes; Crauwels, Herta; Kolobova, Irina; Patel, Natasha; Jamil, Nasir; Van Solingen-Ristea, Rodica; Acuipil, Carolina; Spreen, William
HIV
炎症/感染
微生物学
发表日期：2025
文献求助 收藏

Long-Acting Cabotegravir and Rilpivirine Dosed Every 2 Months in Adults With Human Immunodeficiency Virus 1 Type 1 Infection: 152-Week Results From ATLAS-2M, a Randomized, Open-Label, Phase 3b, Noninferiority Study

在成人人类免疫缺陷病毒1型感染者中，每2个月给予一次长效卡博特韦和利匹韦林：一项随机、开放标签、3b期非劣效性研究ATLAS-2M的152周结果

期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/ciad020
Overton, Edgar T; Richmond, Gary; Rizzardini, Giuliano; Thalme, Anders; Girard, Pierre-Marie; Wong, Alexander; Porteiro, Norma; Swindells, Susan; Reynes, Jacques; Noe, Sebastian; Harrington, Conn; Español, Carlos Martín; Acuipil, Carolina; Aksar, Asma; Wang, Yuanyuan; Ford, Susan L; Crauwels, Herta; van Eygen, Veerle; Van Solingen-Ristea, Rodica; Latham, Christine L; Thiagarajah, Shanker; D'Amico, Ronald; Smith, Kimberly Y; Vandermeulen, Kati; Spreen, William R
HIV
炎症/感染
微生物学
Human
免疫/内分泌
发表日期：2023
文献求助 收藏